Medical information and solutions provider Elsevier Clinical Decision Support, US, has announced that it has developed a quantitative ranking system that enables health plans to better control their medication therapy management (MTM) programmes for Medicare Part D members. The Intervention Priority Score (IPS) is a new feature of Elsevier’s MTM 360, which is powered by the highly accurate modeling technology of MEDai, an Elsevier company. Elsevier and MEDai developed the IPS specifically for health plans seeking to improve their management of MTM programmes for their Medicare Part D business.
The new IPS is embedded in MTM 360 and will enable Medicare Part D sponsors to select members based on a priority ranking of intervention need. MTM 360 also addresses the CMS requirement to assign priority to health plan members who have requested a Comprehensive Medication Review, so those members are moved to the top of the list.
MTM 360 was designed to facilitate the collection, documentation, analysis and reporting of data required as part of CMS’s MTM programme protocols. The solution allows clients to not only select eligible beneficiaries for MTM using CMS rules but also to create specific criteria that align with other initiatives their organisations are currently involved in. MTM 360 allows users to identify, stratify and monitor patient populations to ensure effective and efficient resource allocation. The programme also supplies customisable documentation, communication, and reporting to streamline the MTM delivery process.
Search for more risk analyses tools
